Gupta Ruchika, Gupta Sanjay, Mehrotra Ravi, Sodhani Pushpa
Division of Cytopathology, National Institute of Cancer Prevention and Research, Noida, India. Email: sodhanip@ yahoo.com
Asian Pac J Cancer Prev. 2017 Jun 25;18(6):1461-1467. doi: 10.22034/APJCP.2017.18.6.1461.
Cervical cancer continues to be a major public health problem affecting large numbers of women in many developing countries. Limitations of various screening modalities and the lack of ready availability of a cost-effective point-of-care screening tool have hindered the efficient implementation of population-based screening programs in these settings. It has not proved possible for many countries to adopt cytology as a screening modality due to inadequate infrastructure and trained manpower. However, recent developments, notably design and testing of a low-cost HPV test kit and initiatives by countries like India in developing and putting into operation a framework for large-scale screening of women, have raised hopes that cervical cancer control may be possible even in resource-constrained locations. With the advent of HPV vaccination, primary prevention of cervical cancer also seems a distinct possibility. However, wide availability and acceptability of vaccination is still an unresolved issue for developing countries. The possible future effects of vaccination on test characteristics of various screening strategies also need to be evaluated. This review gathers information on the current status of cervical cancer screening with a special focus on low resource settings. It revisits the strengths and limitations of the available screening modalities for cervical cancer viz. cytology, visual methods and HPV testing, in the context of their applicability in developing countries. In addition, the role of newer HPV-detection methods, for instance DNA, RNA and protein-based techniques, in triage of screen-positive women is discussed. The contemporary issue of impact of HPV vaccination on cervical cancer screening is also addressed briefly. The main highlight of the review is the reference to ‘operational framework guidelines’ for population-based cervical cancer screening, which have recently been formulated and are in the process of being implemented in India. The guidelines may serve as a model for other similar low-resource settings where implementation of cancer screening is desired.
宫颈癌仍然是一个重大的公共卫生问题,影响着许多发展中国家的大量妇女。各种筛查方式的局限性以及缺乏经济高效的即时检测筛查工具,阻碍了这些地区基于人群的筛查项目的有效实施。由于基础设施不足和缺乏训练有素的人力,许多国家尚未证明能够采用细胞学作为筛查方式。然而,最近的进展,特别是低成本HPV检测试剂盒的设计和测试,以及印度等国家在制定和实施大规模妇女筛查框架方面的举措,让人们燃起了希望,即便是在资源有限的地区,宫颈癌控制也有可能实现。随着HPV疫苗接种的出现,宫颈癌的一级预防似乎也很有可能实现。然而,疫苗接种的广泛可得性和可接受性对于发展中国家来说仍是一个未解决的问题。疫苗接种对各种筛查策略检测特征的未来可能影响也需要进行评估。本综述收集了宫颈癌筛查现状的信息,特别关注资源匮乏地区。它重新审视了宫颈癌现有筛查方式的优势和局限性,即细胞学、视觉方法和HPV检测,以及它们在发展中国家的适用性。此外,还讨论了更新的HPV检测方法,如基于DNA、RNA和蛋白质的技术,在对筛查呈阳性的女性进行分流中的作用。HPV疫苗接种对宫颈癌筛查影响的当代问题也进行了简要探讨。该综述的主要亮点是提及了基于人群的宫颈癌筛查的“操作框架指南”,该指南最近已制定并正在印度实施。这些指南可作为其他希望实施癌症筛查的类似资源匮乏地区的模式。